Polysubstituted benzimidazole nucleosides as antiviral agents
US5248672A · kind A · utility
36Cited by
13References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 1990 |
| Grant date | Sep 28, 1993 |
| Priority date | — |
| Expiry date | Nov 1, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel polysubstituted benzimidazole nucleosides and compositions and their use in the treatment of viral infections, particulary those caused by human cytomegalovirus and herpes simplex virus. Such substituted compounds exhibit antiviral properties superior to their parent compounds and low leve PAC SPONSORSHIP This invention was made with government support under Contract No. NO1 Al 42554 and NO1 Al 72641 awarded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The government has certain rights in this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.